Form 10 Explorer
10-Q
Quarterly Report
ACRO BIOMEDICAL CO., LTD.

CIK: 1622996

File #: 000-55643

Period End: Mar 31, 2024

Fiscal Year: 2024

View on EDGAR
Balance Sheet
28 line items · 2 periods
XBRL
ItemMar 31, 2024Dec 31, 2023
Balance Sheets
ASSETS
Current Assets
Cash
151376
Other Non-Operating Current Assets
01,250
Total Current Assets
1511,626
Operating Lease Right-of-Use Asset
46,04152,233
Other Non-Operating Current Assets
4,6004,600
TOTAL ASSETS
50,79258,459
Current Liabilities
Accounts Payable
152,294154,444
Other Current Liabilities
20,00020,000
Due to related parties
102,08488,796
CEO
1,1001,100
Operating Lease Liability, Current
23,40225,335
Total Current Liabilities
297,780288,575
Operating Lease Liability, Non-Current
20,32426,898
TOTAL LIABILITIES
318,104315,473
Preferred Stock
00
Total Stockholders' Equity
60,04260,042
Total Stockholders' Equity
32,299,39632,298,442
Total Stockholders' Equity
(32,626,750)(32,615,498)
Total Stockholders' Deficit
(267,312)(257,014)
Accumulated Deficit
(32,626,750)(32,615,498)
Additional Paid-In Capital
32,299,39632,298,442
Common Stock
60,04260,042
Preferred Stock
00
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
50,79258,459
ACRO BIOMEDICAL CO., LTD. — 10-Q Filing | Form 10 Explorer